APO Research
Talk to an analyst

APO RESEARCH · REPORT

Kidney Transplant Rejection Therapeutics

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Kidney Transplant Rejection Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025192 pages

Choose your research edition.

Industry ResearchKidney Transplant Rejection Therapeutics Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Kidney Transplant Rejection Therapeutics Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Kidney Transplant Rejection Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Kidney Transplant Rejection Therapeutics Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Kidney Transplant Rejection Therapeutics Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Kidney Transplant Rejection Therapeutics market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Kidney Transplant Rejection Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Kidney Transplant Rejection Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Kidney Transplant Rejection Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Kidney Transplant Rejection Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Kidney Transplant Rejection Therapeutics include Novartis AG, GlaxoSmithKline Plc, Pharming Group N.V., Pharmicell, OSE Immunotherapeutics, Opsona Therapeutics Limited, Noorik Biopharmaceuticals AG, Magnus Life Ltd and Mabtech Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Kidney Transplant Rejection Therapeutics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Kidney Transplant Rejection Therapeutics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Kidney Transplant Rejection Therapeutics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Kidney Transplant Rejection Therapeutics market size, projected growth trends, production technologies, key applications, and end-use industries.

Kidney Transplant Rejection Therapeutics Segment by Company

Novartis AG

GlaxoSmithKline Plc

Pharming Group N.V.

Pharmicell

OSE Immunotherapeutics

Opsona Therapeutics Limited

Noorik Biopharmaceuticals AG

Magnus Life Ltd

Mabtech Limited

Kyowa Hakko Kirin

Hansa Medical AB

Grifols, S.A.

Digna Biotech, S.L.

CSL Limited

Kidney Transplant Rejection Therapeutics Segment by Type

Cortina

Azathioprine

Cyclophosphamide

Cyclosporin A

Other

Kidney Transplant Rejection Therapeutics Segment by Application

Clinic

Hospital

ASCs

Others

Kidney Transplant Rejection Therapeutics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Kidney Transplant Rejection Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Kidney Transplant Rejection Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Kidney Transplant Rejection Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Kidney Transplant Rejection Therapeutics market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Kidney Transplant Rejection Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Kidney Transplant Rejection Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Kidney Transplant Rejection Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Kidney Transplant Rejection Therapeutics Industry Trends Table 2. Kidney Transplant Rejection Therapeutics Industry Drivers Table 3. Kidney Transplant Rejection Therapeutics Industry Opportunities and Challenges Table 4. Kidney Transplant Rejection Therapeutics Industry Restraints Table 5. Global Kidney Transplant Rejection Therapeutics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Kidney Transplant Rejection Therapeutics Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Kidney Transplant Rejection Therapeutics Sales Market Share by Manufacturers Table 9. Global Kidney Transplant Rejection Therapeutics Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Kidney Transplant Rejection Therapeutics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Kidney Transplant Rejection Therapeutics Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Kidney Transplant Rejection Therapeutics Manufacturers, Product Type & Application Table 13. Global Kidney Transplant Rejection Therapeutics Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Kidney Transplant Rejection Therapeutics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Cortina Table 17. Major Manufacturers of Azathioprine Table 18. Major Manufacturers of Cyclophosphamide Table 19. Major Manufacturers of Cyclosporin A Table 20. Major Manufacturers of Other Table 21. Global Kidney Transplant Rejection Therapeutics Sales by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Kidney Transplant Rejection Therapeutics Sales by Type (2021-2026) & (k units) Table 23. Global Kidney Transplant Rejection Therapeutics Sales by Type (2027-2032) & (k units) Table 24. Global Kidney Transplant Rejection Therapeutics Sales Market Share by Type (2021-2026) Table 25. Global Kidney Transplant Rejection Therapeutics Sales Market Share by Type (2027-2032) Table 26. Global Kidney Transplant Rejection Therapeutics Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 27. Global Kidney Transplant Rejection Therapeutics Revenue by Type (2021-2026) & (k units) Table 28. Global Kidney Transplant Rejection Therapeutics Revenue by Type (2027-2032) & (k units) Table 29. Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Type (2021-2026) Table 30. Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Clinic Table 32. Major Manufacturers of Hospital Table 33. Major Manufacturers of ASCs Table 34. Major Manufacturers of Others Table 35. Global Kidney Transplant Rejection Therapeutics Sales by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Kidney Transplant Rejection Therapeutics Sales by Application (2021-2026) & (k units) Table 37. Global Kidney Transplant Rejection Therapeutics Sales by Application (2027-2032) & (k units) Table 38. Global Kidney Transplant Rejection Therapeutics Sales Market Share by Application (2021-2026) Table 39. Global Kidney Transplant Rejection Therapeutics Sales Market Share by Application (2027-2032) Table 40. Global Kidney Transplant Rejection Therapeutics Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 41. Global Kidney Transplant Rejection Therapeutics Revenue by Application (2021-2026) & (k units) Table 42. Global Kidney Transplant Rejection Therapeutics Revenue by Application (2027-2032) & (k units) Table 43. Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Application (2021-2026) Table 44. Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Application (2027-2032) Table 45. Global Kidney Transplant Rejection Therapeutics Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Kidney Transplant Rejection Therapeutics Sales by Region (2021-2026) & (k units) Table 47. Global Kidney Transplant Rejection Therapeutics Sales Market Share by Region (2021-2026) Table 48. Global Kidney Transplant Rejection Therapeutics Sales Forecasted by Region (2027-2032) & (k units) Table 49. Global Kidney Transplant Rejection Therapeutics Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Kidney Transplant Rejection Therapeutics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. North America Kidney Transplant Rejection Therapeutics Sales by Country (2021-2026) & (k units) Table 52. North America Kidney Transplant Rejection Therapeutics Sales by Country (2027-2032) & (k units) Table 53. Europe Kidney Transplant Rejection Therapeutics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Europe Kidney Transplant Rejection Therapeutics Sales by Country (2021-2026) & (k units) Table 55. Europe Kidney Transplant Rejection Therapeutics Sales by Country (2027-2032) & (k units) Table 56. Asia Pacific Kidney Transplant Rejection Therapeutics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Asia Pacific Kidney Transplant Rejection Therapeutics Sales by Country (2021-2026) & (k units) Table 58. Asia Pacific Kidney Transplant Rejection Therapeutics Sales by Country (2027-2032) & (k units) Table 59. South America, Middle East and Africa Kidney Transplant Rejection Therapeutics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 60. South America, Middle East and Africa Kidney Transplant Rejection Therapeutics Sales by Country (2021-2026) & (k units) Table 61. South America, Middle East and Africa Kidney Transplant Rejection Therapeutics Sales by Country (2027-2032) & (k units) Table 62. Global Kidney Transplant Rejection Therapeutics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Kidney Transplant Rejection Therapeutics Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Kidney Transplant Rejection Therapeutics Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Region (2021-2026) Table 66. Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Region (2027-2032) Table 67. Novartis AG Company Information Table 68. Novartis AG Business Overview Table 69. Novartis AG Kidney Transplant Rejection Therapeutics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Novartis AG Kidney Transplant Rejection Therapeutics Product Portfolio Table 71. Novartis AG Recent Development Table 72. GlaxoSmithKline Plc Company Information Table 73. GlaxoSmithKline Plc Business Overview Table 74. GlaxoSmithKline Plc Kidney Transplant Rejection Therapeutics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. GlaxoSmithKline Plc Kidney Transplant Rejection Therapeutics Product Portfolio Table 76. GlaxoSmithKline Plc Recent Development Table 77. Pharming Group N.V. Company Information Table 78. Pharming Group N.V. Business Overview Table 79. Pharming Group N.V. Kidney Transplant Rejection Therapeutics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Pharming Group N.V. Kidney Transplant Rejection Therapeutics Product Portfolio Table 81. Pharming Group N.V. Recent Development Table 82. Pharmicell Company Information Table 83. Pharmicell Business Overview Table 84. Pharmicell Kidney Transplant Rejection Therapeutics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Pharmicell Kidney Transplant Rejection Therapeutics Product Portfolio Table 86. Pharmicell Recent Development Table 87. OSE Immunotherapeutics Company Information Table 88. OSE Immunotherapeutics Business Overview Table 89. OSE Immunotherapeutics Kidney Transplant Rejection Therapeutics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. OSE Immunotherapeutics Kidney Transplant Rejection Therapeutics Product Portfolio Table 91. OSE Immunotherapeutics Recent Development Table 92. Opsona Therapeutics Limited Company Information Table 93. Opsona Therapeutics Limited Business Overview Table 94. Opsona Therapeutics Limited Kidney Transplant Rejection Therapeutics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Opsona Therapeutics Limited Kidney Transplant Rejection Therapeutics Product Portfolio Table 96. Opsona Therapeutics Limited Recent Development Table 97. Noorik Biopharmaceuticals AG Company Information Table 98. Noorik Biopharmaceuticals AG Business Overview Table 99. Noorik Biopharmaceuticals AG Kidney Transplant Rejection Therapeutics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Noorik Biopharmaceuticals AG Kidney Transplant Rejection Therapeutics Product Portfolio Table 101. Noorik Biopharmaceuticals AG Recent Development Table 102. Magnus Life Ltd Company Information Table 103. Magnus Life Ltd Business Overview Table 104. Magnus Life Ltd Kidney Transplant Rejection Therapeutics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Magnus Life Ltd Kidney Transplant Rejection Therapeutics Product Portfolio Table 106. Magnus Life Ltd Recent Development Table 107. Mabtech Limited Company Information Table 108. Mabtech Limited Business Overview Table 109. Mabtech Limited Kidney Transplant Rejection Therapeutics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Mabtech Limited Kidney Transplant Rejection Therapeutics Product Portfolio Table 111. Mabtech Limited Recent Development Table 112. Kyowa Hakko Kirin Company Information Table 113. Kyowa Hakko Kirin Business Overview Table 114. Kyowa Hakko Kirin Kidney Transplant Rejection Therapeutics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Kyowa Hakko Kirin Kidney Transplant Rejection Therapeutics Product Portfolio Table 116. Kyowa Hakko Kirin Recent Development Table 117. Hansa Medical AB Company Information Table 118. Hansa Medical AB Business Overview Table 119. Hansa Medical AB Kidney Transplant Rejection Therapeutics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Hansa Medical AB Kidney Transplant Rejection Therapeutics Product Portfolio Table 121. Hansa Medical AB Recent Development Table 122. Grifols, S.A. Company Information Table 123. Grifols, S.A. Business Overview Table 124. Grifols, S.A. Kidney Transplant Rejection Therapeutics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Grifols, S.A. Kidney Transplant Rejection Therapeutics Product Portfolio Table 126. Grifols, S.A. Recent Development Table 127. Digna Biotech, S.L. Company Information Table 128. Digna Biotech, S.L. Business Overview Table 129. Digna Biotech, S.L. Kidney Transplant Rejection Therapeutics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Digna Biotech, S.L. Kidney Transplant Rejection Therapeutics Product Portfolio Table 131. Digna Biotech, S.L. Recent Development Table 132. CSL Limited Company Information Table 133. CSL Limited Business Overview Table 134. CSL Limited Kidney Transplant Rejection Therapeutics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. CSL Limited Kidney Transplant Rejection Therapeutics Product Portfolio Table 136. CSL Limited Recent Development Table 137. Key Raw Materials Table 138. Raw Materials Key Suppliers Table 139. Kidney Transplant Rejection Therapeutics Distributors List Table 140. Kidney Transplant Rejection Therapeutics Customers List Table 141. Research Programs/Design for This Report Table 142. Authors List of This Report Table 143. Secondary Sources Table 144. Primary Sources List of Figures Figure 1. Kidney Transplant Rejection Therapeutics Product Image Figure 2. Global Kidney Transplant Rejection Therapeutics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Kidney Transplant Rejection Therapeutics Market Size (2021-2032) & (US$ Million) Figure 4. Global Kidney Transplant Rejection Therapeutics Sales (2021-2032) & (k units) Figure 5. Global Kidney Transplant Rejection Therapeutics Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Kidney Transplant Rejection Therapeutics Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Cortina Image Figure 9. Azathioprine Image Figure 10. Cyclophosphamide Image Figure 11. Cyclosporin A Image Figure 12. Other Image Figure 13. Global Kidney Transplant Rejection Therapeutics Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Kidney Transplant Rejection Therapeutics Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Kidney Transplant Rejection Therapeutics Sales Market Share by Type (2021-2032) Figure 16. Global Kidney Transplant Rejection Therapeutics Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 17. Global Kidney Transplant Rejection Therapeutics Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Type (2021-2032) Figure 19. Clinic Image Figure 20. Hospital Image Figure 21. ASCs Image Figure 22. Others Image Figure 23. Global Kidney Transplant Rejection Therapeutics Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Kidney Transplant Rejection Therapeutics Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Kidney Transplant Rejection Therapeutics Sales Market Share by Application (2021-2032) Figure 26. Global Kidney Transplant Rejection Therapeutics Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 27. Global Kidney Transplant Rejection Therapeutics Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Application (2021-2032) Figure 29. North America Kidney Transplant Rejection Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 30. North America Kidney Transplant Rejection Therapeutics Sales Market Share by Country (2021-2032) Figure 31. U.S. Kidney Transplant Rejection Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 32. Canada Kidney Transplant Rejection Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 33. Mexico Kidney Transplant Rejection Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Kidney Transplant Rejection Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 35. Europe Kidney Transplant Rejection Therapeutics Sales Market Share by Country (2021-2032) Figure 36. Germany Kidney Transplant Rejection Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 37. France Kidney Transplant Rejection Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 38. U.K. Kidney Transplant Rejection Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 39. Italy Kidney Transplant Rejection Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 40. Netherlands Kidney Transplant Rejection Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Kidney Transplant Rejection Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 42. Asia Pacific Kidney Transplant Rejection Therapeutics Sales Market Share by Country (2021-2032) Figure 43. China Kidney Transplant Rejection Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 44. Japan Kidney Transplant Rejection Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 45. South Korea Kidney Transplant Rejection Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 46. Southeast Asia Kidney Transplant Rejection Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 47. India Kidney Transplant Rejection Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 48. Australia Kidney Transplant Rejection Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Kidney Transplant Rejection Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 50. South America, Middle East and Africa Kidney Transplant Rejection Therapeutics Sales Market Share by Country (2021-2032) Figure 51. Brazil Kidney Transplant Rejection Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 52. South Africa Kidney Transplant Rejection Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 53. Saudi Arabia Kidney Transplant Rejection Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 54. Turkey Kidney Transplant Rejection Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 55. Argentina Kidney Transplant Rejection Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 56. UAE Kidney Transplant Rejection Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 57. Egypt Kidney Transplant Rejection Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 58. Chile Kidney Transplant Rejection Therapeutics Sales and Growth Rate (2021-2032) & (k units) Figure 59. Global Kidney Transplant Rejection Therapeutics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Kidney Transplant Rejection Therapeutics Revenue (2021-2032) & (US$ Million) Figure 62. North America Kidney Transplant Rejection Therapeutics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Kidney Transplant Rejection Therapeutics Revenue (2021-2032) & (US$ Million) Figure 64. Europe Kidney Transplant Rejection Therapeutics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Kidney Transplant Rejection Therapeutics Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Kidney Transplant Rejection Therapeutics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Kidney Transplant Rejection Therapeutics Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Kidney Transplant Rejection Therapeutics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Kidney Transplant Rejection Therapeutics Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Kidney Transplant Rejection Therapeutics Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Cortina
  • Azathioprine
  • Cyclophosphamide
  • Cyclosporin A
  • Other
Applications
  • Clinic
  • Hospital
  • ASCs
  • Others
Companies covered
  • Novartis AG
  • GlaxoSmithKline Plc
  • Pharming Group N.V.
  • Pharmicell
  • OSE Immunotherapeutics
  • Opsona Therapeutics Limited
  • Noorik Biopharmaceuticals AG
  • Magnus Life Ltd
  • Mabtech Limited
  • Kyowa Hakko Kirin
  • Hansa Medical AB
  • Grifols, S.A.
  • Digna Biotech, S.L.
  • CSL Limited

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Kidney Transplant Rejection Therapeutics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Kidney Transplant Rejection Therapeutics Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Kidney Transplant Rejection Therapeutics Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Kidney Transplant Rejection Therapeutics Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Kidney Transplant Rejection Therapeutics Market Dynamics
  1. 2.1 Kidney Transplant Rejection Therapeutics Industry Trends
  2. 2.2 Kidney Transplant Rejection Therapeutics Industry Drivers
  3. 2.3 Kidney Transplant Rejection Therapeutics Industry Opportunities and Challenges
  4. 2.4 Kidney Transplant Rejection Therapeutics Industry Restraints
3 Kidney Transplant Rejection Therapeutics Market by Manufacturers
  1. 3.1 Global Kidney Transplant Rejection Therapeutics Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Kidney Transplant Rejection Therapeutics Sales by Manufacturers (2021-2026)
  3. 3.3 Global Kidney Transplant Rejection Therapeutics Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Kidney Transplant Rejection Therapeutics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Kidney Transplant Rejection Therapeutics Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Kidney Transplant Rejection Therapeutics Manufacturers, Product Type & Application
  7. 3.7 Global Kidney Transplant Rejection Therapeutics Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Kidney Transplant Rejection Therapeutics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Kidney Transplant Rejection Therapeutics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Kidney Transplant Rejection Therapeutics Tier 1, Tier 2, and Tier 3
4 Kidney Transplant Rejection Therapeutics Market by Type
  1. 4.1 Kidney Transplant Rejection Therapeutics Type Introduction
  2. 4.1.1 Cortina
  3. 4.1.2 Azathioprine
  4. 4.1.3 Cyclophosphamide
  5. 4.1.4 Cyclosporin A
  6. 4.1.5 Other
  7. 4.2 Global Kidney Transplant Rejection Therapeutics Sales by Type
  8. 4.2.1 Global Kidney Transplant Rejection Therapeutics Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Kidney Transplant Rejection Therapeutics Sales by Type (2021-2032)
  10. 4.2.3 Global Kidney Transplant Rejection Therapeutics Sales Market Share by Type (2021-2032)
  11. 4.3 Global Kidney Transplant Rejection Therapeutics Revenue by Type
  12. 4.3.1 Global Kidney Transplant Rejection Therapeutics Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Kidney Transplant Rejection Therapeutics Revenue by Type (2021-2032)
  14. 4.3.3 Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Type (2021-2032)
5 Kidney Transplant Rejection Therapeutics Market by Application
  1. 5.1 Kidney Transplant Rejection Therapeutics Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 ASCs
  5. 5.1.4 Others
  6. 5.2 Global Kidney Transplant Rejection Therapeutics Sales by Application
  7. 5.2.1 Global Kidney Transplant Rejection Therapeutics Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Kidney Transplant Rejection Therapeutics Sales by Application (2021-2032)
  9. 5.2.3 Global Kidney Transplant Rejection Therapeutics Sales Market Share by Application (2021-2032)
  10. 5.3 Global Kidney Transplant Rejection Therapeutics Revenue by Application
  11. 5.3.1 Global Kidney Transplant Rejection Therapeutics Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Kidney Transplant Rejection Therapeutics Revenue by Application (2021-2032)
  13. 5.3.3 Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Application (2021-2032)
6 Global Kidney Transplant Rejection Therapeutics Sales by Region
  1. 6.1 Global Kidney Transplant Rejection Therapeutics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Kidney Transplant Rejection Therapeutics Sales by Region (2021-2032)
  3. 6.2.1 Global Kidney Transplant Rejection Therapeutics Sales by Region (2021-2026)
  4. 6.2.2 Global Kidney Transplant Rejection Therapeutics Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Kidney Transplant Rejection Therapeutics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Kidney Transplant Rejection Therapeutics Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Kidney Transplant Rejection Therapeutics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Kidney Transplant Rejection Therapeutics Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Kidney Transplant Rejection Therapeutics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Kidney Transplant Rejection Therapeutics Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Kidney Transplant Rejection Therapeutics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Kidney Transplant Rejection Therapeutics Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Kidney Transplant Rejection Therapeutics Revenue by Region
  1. 7.1 Global Kidney Transplant Rejection Therapeutics Revenue by Region
  2. 7.1.1 Global Kidney Transplant Rejection Therapeutics Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Kidney Transplant Rejection Therapeutics Revenue by Region (2021-2026)
  4. 7.1.3 Global Kidney Transplant Rejection Therapeutics Revenue by Region (2027-2032)
  5. 7.1.4 Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Kidney Transplant Rejection Therapeutics Revenue (2021-2032)
  8. 7.2.2 North America Kidney Transplant Rejection Therapeutics Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Kidney Transplant Rejection Therapeutics Revenue (2021-2032)
  11. 7.3.2 Europe Kidney Transplant Rejection Therapeutics Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Kidney Transplant Rejection Therapeutics Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Kidney Transplant Rejection Therapeutics Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Kidney Transplant Rejection Therapeutics Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Kidney Transplant Rejection Therapeutics Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis AG
  2. 8.1.1 Novartis AG Company Information
  3. 8.1.2 Novartis AG Business Overview
  4. 8.1.3 Novartis AG Kidney Transplant Rejection Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Novartis AG Kidney Transplant Rejection Therapeutics Product Portfolio
  6. 8.1.5 Novartis AG Recent Developments
  7. 8.2 GlaxoSmithKline Plc
  8. 8.2.1 GlaxoSmithKline Plc Company Information
  9. 8.2.2 GlaxoSmithKline Plc Business Overview
  10. 8.2.3 GlaxoSmithKline Plc Kidney Transplant Rejection Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 GlaxoSmithKline Plc Kidney Transplant Rejection Therapeutics Product Portfolio
  12. 8.2.5 GlaxoSmithKline Plc Recent Developments
  13. 8.3 Pharming Group N.V.
  14. 8.3.1 Pharming Group N.V. Company Information
  15. 8.3.2 Pharming Group N.V. Business Overview
  16. 8.3.3 Pharming Group N.V. Kidney Transplant Rejection Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pharming Group N.V. Kidney Transplant Rejection Therapeutics Product Portfolio
  18. 8.3.5 Pharming Group N.V. Recent Developments
  19. 8.4 Pharmicell
  20. 8.4.1 Pharmicell Company Information
  21. 8.4.2 Pharmicell Business Overview
  22. 8.4.3 Pharmicell Kidney Transplant Rejection Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pharmicell Kidney Transplant Rejection Therapeutics Product Portfolio
  24. 8.4.5 Pharmicell Recent Developments
  25. 8.5 OSE Immunotherapeutics
  26. 8.5.1 OSE Immunotherapeutics Company Information
  27. 8.5.2 OSE Immunotherapeutics Business Overview
  28. 8.5.3 OSE Immunotherapeutics Kidney Transplant Rejection Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 OSE Immunotherapeutics Kidney Transplant Rejection Therapeutics Product Portfolio
  30. 8.5.5 OSE Immunotherapeutics Recent Developments
  31. 8.6 Opsona Therapeutics Limited
  32. 8.6.1 Opsona Therapeutics Limited Company Information
  33. 8.6.2 Opsona Therapeutics Limited Business Overview
  34. 8.6.3 Opsona Therapeutics Limited Kidney Transplant Rejection Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Opsona Therapeutics Limited Kidney Transplant Rejection Therapeutics Product Portfolio
  36. 8.6.5 Opsona Therapeutics Limited Recent Developments
  37. 8.7 Noorik Biopharmaceuticals AG
  38. 8.7.1 Noorik Biopharmaceuticals AG Company Information
  39. 8.7.2 Noorik Biopharmaceuticals AG Business Overview
  40. 8.7.3 Noorik Biopharmaceuticals AG Kidney Transplant Rejection Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Noorik Biopharmaceuticals AG Kidney Transplant Rejection Therapeutics Product Portfolio
  42. 8.7.5 Noorik Biopharmaceuticals AG Recent Developments
  43. 8.8 Magnus Life Ltd
  44. 8.8.1 Magnus Life Ltd Company Information
  45. 8.8.2 Magnus Life Ltd Business Overview
  46. 8.8.3 Magnus Life Ltd Kidney Transplant Rejection Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Magnus Life Ltd Kidney Transplant Rejection Therapeutics Product Portfolio
  48. 8.8.5 Magnus Life Ltd Recent Developments
  49. 8.9 Mabtech Limited
  50. 8.9.1 Mabtech Limited Company Information
  51. 8.9.2 Mabtech Limited Business Overview
  52. 8.9.3 Mabtech Limited Kidney Transplant Rejection Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Mabtech Limited Kidney Transplant Rejection Therapeutics Product Portfolio
  54. 8.9.5 Mabtech Limited Recent Developments
  55. 8.10 Kyowa Hakko Kirin
  56. 8.10.1 Kyowa Hakko Kirin Company Information
  57. 8.10.2 Kyowa Hakko Kirin Business Overview
  58. 8.10.3 Kyowa Hakko Kirin Kidney Transplant Rejection Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Kyowa Hakko Kirin Kidney Transplant Rejection Therapeutics Product Portfolio
  60. 8.10.5 Kyowa Hakko Kirin Recent Developments
  61. 8.11 Hansa Medical AB
  62. 8.11.1 Hansa Medical AB Company Information
  63. 8.11.2 Hansa Medical AB Business Overview
  64. 8.11.3 Hansa Medical AB Kidney Transplant Rejection Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Hansa Medical AB Kidney Transplant Rejection Therapeutics Product Portfolio
  66. 8.11.5 Hansa Medical AB Recent Developments
  67. 8.12 Grifols, S.A.
  68. 8.12.1 Grifols, S.A. Company Information
  69. 8.12.2 Grifols, S.A. Business Overview
  70. 8.12.3 Grifols, S.A. Kidney Transplant Rejection Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Grifols, S.A. Kidney Transplant Rejection Therapeutics Product Portfolio
  72. 8.12.5 Grifols, S.A. Recent Developments
  73. 8.13 Digna Biotech, S.L.
  74. 8.13.1 Digna Biotech, S.L. Company Information
  75. 8.13.2 Digna Biotech, S.L. Business Overview
  76. 8.13.3 Digna Biotech, S.L. Kidney Transplant Rejection Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Digna Biotech, S.L. Kidney Transplant Rejection Therapeutics Product Portfolio
  78. 8.13.5 Digna Biotech, S.L. Recent Developments
  79. 8.14 CSL Limited
  80. 8.14.1 CSL Limited Company Information
  81. 8.14.2 CSL Limited Business Overview
  82. 8.14.3 CSL Limited Kidney Transplant Rejection Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 CSL Limited Kidney Transplant Rejection Therapeutics Product Portfolio
  84. 8.14.5 CSL Limited Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Kidney Transplant Rejection Therapeutics Value Chain Analysis
  2. 9.1.1 Kidney Transplant Rejection Therapeutics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Kidney Transplant Rejection Therapeutics Production Mode & Process
  6. 9.2 Kidney Transplant Rejection Therapeutics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Kidney Transplant Rejection Therapeutics Distributors
  9. 9.2.3 Kidney Transplant Rejection Therapeutics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst